Vasculitis & polymyalgia rheumatica

Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Subclinical PMR findings are frequently detected by PET-CT in patients with apparently isolated GCA, supporting the concept of a GCA-PMR spectrum disease.

Study context

Population
Patients with newly diagnosed giant cell arteritis (GCA) who underwent 18F-FDG PET-CT at diagnosis, single centre
Participants
168 patients
Exposure
Subclinical polymyalgia rheumatica (PMR) vs clinical PMR vs pure GCA, classified by PET findings and clinical symptoms
  • Subclinical PMRn = 57
Outcome
Prevalence of subclinical PMR in patients with apparently isolated GCA
Follow-up
At diagnosis
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

PET findings consistent with subclinical PMR in apparently isolated GCA

Subclinical PMR

56%

57

Observational data: associations, not effects.

Further findings

OutcomeP value
Large-vessel involvement, subclinical PMR vs pure GCASubclinical PMR vs Pure GCA · thoracic aorta; greater involvement in subclinical PMRP = 0.023
Large-vessel involvement, subclinical PMR vs pure GCASubclinical PMR vs Pure GCA · abdominal aorta; greater involvement in subclinical PMRP = 0.0001
Large-vessel involvement, subclinical PMR vs pure GCASubclinical PMR vs Pure GCA · supra-aortic trunks; greater involvement in subclinical PMRP = 0.007

Musculoskeletal FDG uptake

Less extensive musculoskeletal FDG uptake in subclinical PMR than in clinical PMR
Compared with pure PMR, a milder and more localized inflammatory pattern, mainly affecting the shoulder and pelvic girdles

Cranial manifestations, severe ischaemic events, systemic inflammation, relapse rates

No significant differences across groups

Original publication

Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis. Rheumatology (Oxford). Published 2 June 2026. doi:10.1093/rheumatology/keag285

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.